ICI 182,780 (‘FASLODEX’) 250 mg monthly Intramuscular (I.M.) injection shows consistent Pharmacokinetic (PK) profiles when given as either 1 × 5 ml or 2 × 2.5 ml injections in postmenopausal women with Advanced Breast Cancer (ABC)

✍ Scribed by J.F.R. Robertson; B. Erikstein; C.K. Osborne; J. Pippen; M. Harrison

• Book ID: 117657602
• Publisher: Elsevier Science
• Year: 2001
• Tongue: English
• Weight: 261 KB
• Volume: 37
• Category: Article
• ISSN: 0959-8049
• DOI: 10.1016/s0959-8049(01)80056-3